Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio
Lantheus Holdings, Inc · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $99.30
+11% in 3d after detection
Post-detection moves
1h
—
1d
+3.4%
3d
+11%
7d
+6.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS